No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditions
|
- |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ vaginae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of cervix uteri
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of cervix uteri
- In situ neoplasms
- In situ neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5402 | 5402 | - |
| Only index persons | 5151 | 5151 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.15 | - |
| Only index persons | 0.19 | 0.19 | - |
| Median age at first event (years) | |||
| Whole population | - | 36.09 | - |
| Only index persons | - | 35.80 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3866 | 3866 | - |
| Unadjusted period prevalence (%) | 1.32 | 1.32 | - |
| Median age at first event (years) | 35.40 | 35.40 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3487
- Matched controls
- 34870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
25.4
323.0
2461
3005
LDA10
NOMESCO Finland
Curettage of cervix uteri
16.7
323.0
1146
994
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
85.4
323.0
2394
871
ULA02
NOMESCO Finland
Kolposcopy
38.7
323.0
2720
2923
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
+∞
323.0
339
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
+∞
323.0
2451
*
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
+∞
323.0
633
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
17.2
323.0
2287
3471
N87.1
ICD-10 Finland
Moderate cervical dysplasia
23.3
323.0
875
494
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
26.3
323.0
2117
1933
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
169.3
323.0
2099
310
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
+∞
239.4
227
*
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
+∞
162.8
155
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
6.5
146.4
407
691
8077/2-C53.1
ICD-O-3
Squamous intraepithelial neoplasia, high grade of exocervix
+∞
142.7
136
*
115
Kela drug reimbursment
Breast cancer
+∞
142.7
136
*
PJA12
NOMESCO Finland
Sentinel node biopsy
151.2
124.1
131
9
LEB00
NOMESCO Finland
Biopsy of vagina
10.8
115.2
230
227
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
+∞
108.9
104
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
108.9
104
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.1
94.4
1751
11286
2331A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Cervix uteri
+∞
94.2
90
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
8.2
92.9
217
281
23400
ICD-8 Finland
Neoplasm of unspecified nature of uterus, Carcinoma in situ of cervix uteri
+∞
84.7
81
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
82.6
79
*
A04AA02
ATC
granisetron; systemic, transdermal
72.5
80.7
92
13
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
170.0
79.4
83
5
H02AB02
ATC
dexamethasone; systemic
11.4
78.4
151
138
8326
FHL
Batch conization
32.9
72.7
96
30
ZXC00
NOMESCO Finland
Use of diathermy
13.9
71.9
126
94
HAC20
NOMESCO Finland
Total mastectomy
153.2
71.2
75
5
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
71.1
68
*
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
67.9
65
*
130
Kela drug reimbursment
Malignant tumour
+∞
67.9
65
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
670.9
67.2
66
*
A04AA55
ATC
palonosetron, combinations; systemic
217.2
62.3
64
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
213.8
61.3
63
*
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
13.2
58.8
105
82
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.1
57.5
736
3862
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
179.3
51.0
53
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
14.5
47.5
81
57
L02BA01
ATC
tamoxifen; oral
40.0
47.0
59
15
L03AA13
ATC
pegfilgrastim; parenteral
+∞
44.9
43
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
37.9
44.1
56
15
L01BC06
ATC
capecitabine; oral
+∞
42.8
41
*
128
Kela drug reimbursment
Cancers of female genital organs
412.3
41.2
41
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
40.7
39
*
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
12.4
40.6
74
61
WF002
NOMESCO Finland
Radical radiotherapy
36.9
40.0
51
14
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
6.3
39.2
107
174
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
65.1
39.1
45
7
LCA06
NOMESCO Finland
Biopsy of endometrium
2.0
39.0
566
3075
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
39.0
187
545
X86
ICPC
Abnormal cervix smear
5.2
38.9
124
244
ZX080
NOMESCO Finland
Image guided radiotherapy
103.7
37.8
41
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
+∞
37.6
36
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
361.0
36.0
36
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
81.0
35.9
40
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
79.0
34.9
39
5
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
124.6
34.7
37
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.5
34.0
278
1154
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
121.2
33.7
36
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.3
31
*
8140/2-C53.1
ICD-O-3
Adenocarcinoma in situ, NOS, of exocervix
+∞
32.3
31
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
3.7
32.2
148
417
C50.99
ICD-10 Finland
Breast, unspecified
166.5
31.7
33
*
8140/2-C53.0
ICD-O-3
Adenocarcinoma in situ, NOS, of endocervix
+∞
31.3
30
*
G01AA10
ATC
clindamycin; vaginal
1.7
30.8
786
5120
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
29.2
28
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
29.2
28
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
+∞
29.2
28
*
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
+∞
29.2
28
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
28.2
27
*
HA1AA
NOMESCO Finland
X-ray mammography
3.1
27.5
156
514
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
27.1
26
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
27.1
26
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.1
26
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
26.5
214
883
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
3.5
26.2
128
380
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
3.3
26.1
135
419
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
26.1
25
*
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
8.3
25.5
57
70
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
50.4
25.2
30
6
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
25.0
24
*
C50
ICD-10 Finland
Malignant neoplasm of breast
58.4
25.0
29
5
JN4AD
NOMESCO Finland
Body CT examination
4.5
25.0
90
204
R87.2
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances
14.8
24.7
41
28
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
48.7
24.3
29
6
L03AA02
ATC
filgrastim; parenteral
34.7
24.3
31
9
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
24.0
23
*
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
24.0
23
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
87.4
23.7
26
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
241.6
23.7
24
*
6221C
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]
20.2
23.0
34
17
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
22.9
22
*
X76
ICPC
Malignant neoplasm breast female
+∞
22.9
22
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
22.9
22
*
62191
ICD-8 Finland
Other diseases of cervix, Dysplasia portionis uteri
9.0
22.7
48
54
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.5
22.7
110
325
A04AD12
ATC
aprepitant; systemic
231.4
22.6
23
*
18000
ICD-8 Finland
NA
+∞
21.9
21
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
21.9
21
*
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.6
21.8
164
649
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
17.2
21.8
34
20
NK6AN
NOMESCO Finland
Total body bone isotope imaging
38.9
21.7
27
7
N89.0
ICD-10 Finland
Mild vaginal dysplasia
8.6
21.3
46
54
ZX090
NOMESCO Finland
Other technic of radiotherapy
60.4
20.9
24
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
20.8
20
*
L02BG06
ATC
exemestane; oral
+∞
20.8
20
*
SPAT1193
SPAT
Pap smear
1.6
20.7
623
4187
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
18.4
20.4
31
17
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
19.8
19
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
19.8
19
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
19.8
19
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.5
19.5
160
665
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
40.3
19.5
24
6
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
19.3
108
357
TLC02
NOMESCO Finland
Simple extraction of IUD
2.0
19.1
244
1245
Z51.5
ICD-10 Finland
Palliative care
7.8
18.8
43
56
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
191.0
18.5
19
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
17.7
17
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
180.9
17.5
18
*
P01AB01
ATC
metronidazole; oral, rectal
1.4
17.5
1391
11332
B01AB10
ATC
tinzaparin; parenteral
2.6
17.3
131
524
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
31.6
17.0
22
7
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
16.7
16
*
8010/2-C53.9
ICD-O-3
Carcinoma in situ, NOS, of cervix uteri
+∞
16.7
16
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
16.7
16
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
16.7
16
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
16.7
479
3165
N90.0
ICD-10 Finland
Mild vulvar dysplasia
8.4
16.7
36
43
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
90.5
16.6
18
*
Z51.0
ICD-10 Finland
Radiotherapy session
170.8
16.5
17
*
WX110
NOMESCO Finland
Local anesthesy
1.4
16.5
2344
20908
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
23.1
16.4
23
10
R87.9
ICD-10 Finland
Abnormal findings in specimens from female genital organs, unspecified abnormal finding
9.2
15.6
32
35
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
15.6
15
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
+∞
15.6
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.6
15
*
WF004
NOMESCO Finland
Palliative radiotherapy
160.7
15.5
16
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
15.4
897
6885
JN4BD
NOMESCO Finland
Extensive body CT
2.6
15.3
108
416
SPAT1263
SPAT
Sampling
1.3
15.1
1412
11719
N07BA03
ATC
varenicline; oral
2.1
15.1
177
875
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
56.9
14.8
17
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
5.9
14.6
40
68
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
14.6
14
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
14.6
14
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
14.6
14
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
14.6
14
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
14.6
14
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
14.6
14
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
X23
ICPC
Fear sexually transm dis female
1.6
14.0
337
2123
TQW20
NOMESCO Finland
Tatoe
23.9
13.8
19
8
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
75.4
13.6
15
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
13.5
13
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
13.5
13
*
N87
ICD-10 Finland
Dysplasia of cervix uteri
16.2
13.4
21
13
Z20.2
ICD-10 Finland
Contact with and exposure to infections with a predominantly sexual mode of transmission
2.2
13.3
132
607
N02AA05
ATC
oxycodone; systemic
1.9
13.3
193
1036
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
12.5
275
1690
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
12.5
12
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.5
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
20.1
12.4
18
9
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
2.6
12.1
88
347
X92
ICPC
Chlamydia infection genital female
2.5
12.1
91
365
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
13.4
11.9
20
15
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.9
11.8
167
890
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.5
11.7
505
3646
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
11.5
11
*
WX402
NOMESCO Finland
General anaesthesia
1.5
11.4
413
2869
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
11.4
87
352
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
4.7
11.3
37
79
A63.8
ICD-10 Finland
Other specified predominantly sexually transmitted diseases
7.0
11.3
27
39
XX1AD
NOMESCO Finland
Other CT-examination
35.1
11.3
14
*
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
10.6
11.2
21
20
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.5
11.2
352
2372
N76.0
ICD-10 Finland
Acute vaginitis
1.5
11.1
342
2295
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.1
11.0
21
21
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
10.4
10
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
10.4
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
10.4
10
*
8077/2-C53.0
ICD-O-3
Squamous intraepithelial neoplasia, high grade of endocervix
+∞
10.4
10
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
10.4
10
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
10.4
10
*
A04AA01
ATC
ondansetron; systemic, rectal
2.2
10.4
101
464
LCD10
NOMESCO Finland
Vaginal hysterectomy
2.1
10.3
117
573
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.1
10.3
31
61
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
10.0
73
290
W11
ICPC
Contraception oral
1.4
10.0
556
4201
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
20.1
9.8
14
7
L02BG03
ATC
anastrozole; oral
15.1
9.5
15
10
N93.0
ICD-10 Finland
Postcoital and contact bleeding
3.0
9.5
51
169
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
7.5
9.4
21
28
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
9.4
9
*
394
Kela drug reimbursment
Palbociclib
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
1501
Kela drug reimbursment
Palbociclib
+∞
9.4
9
*
1CD02
NOMESCO Finland
NA
+∞
9.4
9
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
7.3
9.2
21
29
6221B
ICD-9 Finland
Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]
13.7
9.2
15
11
ZXC96
NOMESCO Finland
Robot assisted procedure
4.7
9.0
29
62
SPAT1301
SPAT
No procedures
1.3
8.8
876
7205
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
8.7
981
8198
D06BB04
ATC
podophyllotoxin; topical
1.6
8.7
253
1674
4044
NOMESCO Finland
NA
14.0
8.7
14
10
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
50.1
8.7
10
*
SPAT1312
SPAT
General health counselling
1.3
8.5
1047
8835
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
27.6
8.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
90.3
8.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
90.3
8.4
9
*
SPAT1153
SPAT
Removal of sutures
1.3
8.4
680
5432
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
8.3
8
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
8.3
8
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
8.2
1322
11504
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
8.2
781
6381
D06BB10
ATC
imiquimod; topical
1.8
8.1
145
842
X85
ICPC
Cervical disease NOS
8.9
8.0
16
18
WZC30
NOMESCO Finland
Teaching
1.6
7.9
211
1368
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
2.1
7.9
81
383
SPAT1308
SPAT
Sexual health counselling
1.3
7.9
762
6229
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
7.8
774
6345
N02BE01
ATC
paracetamol; systemic, rectal
1.3
7.8
2692
25389
ZZR00
NOMESCO Finland
Flap of skin
7.0
7.8
18
26
A79
ICPC
Malignancy NOS
45.1
7.7
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
45.1
7.7
9
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
7.6
248
1682
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
25.1
7.6
10
*
T74.1
ICD-10 Finland
Physical abuse
2.1
7.4
75
353
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
80.3
7.4
8
*
T810, N872
ICD-10 Finland
NA
+∞
7.3
7
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
7.3
7
*
D06.7
ICD-10 Finland
Carcinoma in situ: Other parts of cervix
+∞
7.3
7
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
7.3
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
7.3
7
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
7.3
7
*
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
7.2
108
593
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.1
7.0
36
118
J01DB01
ATC
cefalexin; oral
1.2
7.0
2658
25124
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.5
6.9
52
212
SPAT1283
SPAT
Restricted health certificate
1.3
6.9
840
7052
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.8
2446
22927
N06AX11
ATC
mirtazapine; oral
1.2
6.8
881
7447
HAB99
NOMESCO Finland
Other partial excision of mammary gland
3.0
6.8
36
121
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
5.3
6.8
19
36
ZX120
NOMESCO Finland
Intravenous
1.6
6.6
153
961
SPAT1238
SPAT
Brief therapy
1.9
6.5
89
475
N05CF01
ATC
zopiclone; oral
1.3
6.5
705
5827
LDB00
NOMESCO Finland
Excision of lesion of cervix uteri
2.5
6.5
49
200
D82
ICPC
Teeth/gum disease
1.2
6.5
1181
10348
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.8
6.4
38
136
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
0.8
6.4
358
4611
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
70.0
6.4
7
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
70.0
6.4
7
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
70.0
6.4
7
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.9
6.3
87
466
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.2
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.2
6
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
6.2
6
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
6.2
6
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
6.2
6
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
6.2
6
*
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
6.2
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.2
6
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
6.2
6
*
L02BA03
ATC
fulvestrant; parenteral
+∞
6.2
6
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
6.2
6
*
192
Kela drug reimbursment
Fulvestrant
+∞
6.2
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.2
6
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
6.2
6
*
L01XE33
ATC
[U] palbociclib; oral
+∞
6.2
6
*
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
4.3
6.2
21
49
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
6.2
905
7741
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
6.2
1028
8910
LCH11
NOMESCO Finland
Pharmacologic abortion
1.4
6.1
244
1730
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
5.7
6.1
16
28
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.1
6.1
66
324
R87.8
ICD-10 Finland
Abnormal findings in specimens from female genital organs, other abnormal findings
4.0
6.1
22
55
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
6.0
58
269
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
2478
12312
3.82
307.65
3.1
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
934
881
13.66
307.65
2.6
1.6
—
—
—
0
0
(4035726)
554
835
7.58
307.65
1.4
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1234
2080
8.25
307.65
2.6
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2521
10689
4.90
307.65
2.8
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
470
208
25.59
307.65
2.6
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
67
57
11.94
66.15
3.0
1.2
u/ml
36.2
39.7
0.04
62
52
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
41
14
29.59
61.60
1.8
1.0
ug/l
1.7
2.1
—
25
7
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1276
8446
1.76
55.05
2.3
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1386
9453
1.73
53.38
2.4
2.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
42
28
15.15
47.68
4.8
1.1
u/ml
28.8
24.9
0.14
42
28
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
229
945
2.51
35.33
3.6
1.6
ug/l
11.3
18.3
0.19
181
641
(3002256) Pathology report gross observation
551
3193
1.85
35.18
1.3
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
705
4916
1.53
21.25
1.8
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1832
15268
1.38
20.79
3.9
3.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
873
6402
1.47
20.50
2.0
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
34
61
5.61
18.19
1.2
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
327
1994
1.70
17.01
2.3
1.5
u/ml
32.6
27.2
0.48
314
1923
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1528
12687
1.34
16.39
5.4
3.3
umol/l
9.0
9.7
4.13
1437
11762
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1374
11337
1.33
15.02
5.8
4.5
mmol/l
1.2
1.2
0.98
1126
9556
(3024561) Albumin [Mass/volume] in Serum or Plasma
1235
10091
1.33
14.27
4.5
3.6
g/l
36.6
36.9
0.92
1156
9309
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
24
39
6.19
14.19
5.5
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
43
5.85
13.98
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1148
9336
1.33
13.56
1.9
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
559
4104
1.42
12.43
2.2
2.2
u/l
4996.3
6610.1
0.63
219
1796
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1210
10019
1.30
12.28
5.0
4.1
mmol/l
1.2
1.2
1.09
1076
8996
(40761536) Microorganisms panel - Urine sediment
433
3055
1.47
11.89
3.5
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2337
21086
1.27
11.67
6.9
5.1
u/l
70.8
70.4
0.23
2177
19708
(3029937) Albumin [Presence] in Urine by Test strip
1077
8831
1.30
11.63
3.8
3.5
estimate
0.0
0.0
0.13
456
3363
(40768793) Breast Pathology biopsy report
96
445
2.19
11.50
1.3
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
258
1657
1.60
10.93
2.1
2.2
g/l
0.2
0.2
0.76
237
1543
(3032080) INR in Blood by Coagulation assay
976
7997
1.29
10.40
5.8
5.4
inr
1.1
1.1
1.33
360
2762
(3015377) Calcium [Moles/volume] in Serum or Plasma
990
8130
1.29
10.36
3.0
1.8
mmol/l
2.3
2.3
0.34
895
7149
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
269
1769
1.56
10.31
3.2
2.3
mmol/l
1.2
1.2
0.36
228
1468
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
93
459
2.05
9.54
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1500
13076
1.24
9.24
3.7
3.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1452
12649
1.24
8.91
2.1
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
625
4927
1.32
8.70
3.6
3.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3259
31046
1.32
8.64
10.4
8.8
mmol/l
3.9
3.9
0.37
3127
30038
(3009261) Glucose [Presence] in Urine by Test strip
1877
16833
1.22
8.62
3.6
3.3
estimate
0.0
0.0
2.27
449
3356
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
843
6934
1.28
8.47
1.8
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1861
16718
1.22
8.26
4.8
4.4
estimate
0.0
0.0
1.34
461
3398
(3019550) Sodium [Moles/volume] in Serum or Plasma
3247
30956
1.31
8.26
10.3
8.8
mmol/l
139.5
139.5
0.43
3125
30037
(3019060) Gas panel - Arterial blood
151
919
1.67
8.01
3.7
4.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1872
16864
1.21
7.96
8.3
6.6
e9/l
4.0
4.1
0.11
1698
14789
(3012095) Magnesium [Moles/volume] in Serum or Plasma
421
3175
1.37
7.86
3.0
2.3
mmol/l
0.8
0.8
2.00
390
2937
(3002179) Metamyelocytes/100 leukocytes in Blood
288
2040
1.44
7.73
3.9
3.8
%
1.2
0.3
0.72
61
284
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
8
15.04
7.71
1.3
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
337
2461
1.40
7.64
1.7
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
312
2250
1.42
7.60
2.5
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1847
16666
1.21
7.58
3.5
3.2
estimate
0.0
0.0
1.15
442
3295
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3403
32729
1.33
7.56
10.9
9.1
mg/l
19.5
17.9
2.08
2646
24812
(3021589) Normoblasts [#/volume] in Blood
1543
13719
1.21
7.30
8.5
7.1
e9/l
0.0
0.0
1.93
1334
11272
(3003694) ABO and Rh group [Type] in Blood
1340
11761
1.21
7.24
1.8
1.8
—
—
—
0
0
(3013512) EKG study
742
6120
1.26
7.17
2.9
2.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
939
7965
1.24
7.06
4.2
3.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
292
2115
1.41
6.95
4.2
4.1
%
0.1
0.0
0.68
74
338
(3041096) Erythrocytes [Presence] in Urine by Automated
1127
9755
1.22
6.95
3.3
2.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
233
1625
1.46
6.81
4.3
2.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
299
2185
1.40
6.77
4.2
4.0
%
0.8
0.4
0.68
76
359
(3018418) pH of Serum or Plasma
795
6652
1.25
6.74
3.7
2.9
ph
7.4
7.4
0.17
185
1178
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
54
249
2.19
6.71
1.1
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
995
8534
1.22
6.67
2.5
2.2
u/l
51.6
56.0
3.31
911
7895
(3025159) Blasts/100 leukocytes in Blood
284
2065
1.41
6.62
4.1
4.1
%
0.0
0.3
0.52
63
306
(3010421) pH of Blood
92
515
1.81
6.62
2.8
2.5
ph
7.4
7.4
1.21
73
418
(3016502) Oxygen saturation in Arterial blood
214
1479
1.47
6.56
6.2
6.7
%
95.1
96.0
0.75
203
1418
(3003338) MCHC [Mass/volume]
2838
29795
0.82
6.50
13.3
11.7
g/l
332.4
331.9
1.89
2816
29564
(4281824)
46
201
2.30
6.50
1.0
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2507
23443
1.20
6.47
3.8
3.7
mm/h
9.6
9.5
0.04
2322
22080
(3037467) Urinalysis macro (dipstick) panel - Urine
2484
23209
1.20
6.46
4.2
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1744
15822
1.19
6.29
4.0
3.5
mmol/l
6.2
6.3
0.45
1551
13919
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
268
1948
1.40
6.27
4.1
3.1
u/l
226.1
218.8
0.58
251
1824
(3031040) Bacteria [#/volume] in Urine by Automated count
2411
22495
1.19
6.26
4.1
4.0
e6/l
1983.3
1677.0
0.08
19
237
(3027801) Oxygen [Partial pressure] in Arterial blood
241
1722
1.43
6.21
6.2
6.2
kpa
12.9
13.0
0.03
229
1636
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
241
1722
1.43
6.21
6.2
6.2
kpa
5.0
5.0
0.29
228
1639
(3026008) Bacteria identified in Urine by Culture
1078
9399
1.20
6.01
2.6
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
370
2858
1.33
5.89
4.4
4.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3587
34947
1.37
5.85
10.6
8.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
71
382
1.87
5.84
4.3
2.3
u/ml
103.1
52.5
0.46
59
305
(40767503) Oxygen content in Capillary blood by calculation
70
376
1.88
5.79
2.3
2.0
%
17.3
17.0
0.23
39
181
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
970
8402
1.21
5.76
2.6
2.6
ng/l
35.7
35.8
0.00
414
3499
(42870588) Differential panel, method unspecified - Blood
1069
9347
1.20
5.73
5.7
5.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
47
221
2.14
5.62
3.1
2.6
%
1.0
1.1
0.04
34
168
(3012501) Base excess in Blood by calculation
75
420
1.80
5.46
3.0
2.6
mmol/l
2.1
2.2
0.10
38
242
(3007853) Bacteria identified in Skin by Aerobe culture
415
3296
1.29
5.40
1.5
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
197
1395
1.43
5.38
7.1
7.0
g/l
119.7
121.6
0.73
189
1338
(3003396) Base excess in Arterial blood by calculation
236
1727
1.39
5.34
6.2
6.2
mmol/l
0.7
0.8
0.14
174
1266
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
418
3331
1.29
5.30
1.7
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
110
699
1.59
5.05
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
409
3277
1.28
4.97
1.8
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
215
1584
1.38
4.71
1.6
1.5
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
13
33
3.95
4.71
1.6
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
99
625
1.60
4.69
5.0
4.8
%
0.9
0.9
0.71
94
586
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
102
651
1.58
4.62
1.3
1.3
u/ml
167.8
104.1
0.84
25
149
(3008152) Bicarbonate [Moles/volume] in Arterial blood
140
958
1.48
4.61
6.2
6.4
mmol/l
24.4
24.1
0.37
129
881
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3487
33982
1.27
4.54
8.8
7.4
u/l
23.3
23.2
0.12
3362
32927
(3026782) Osmolality of Urine
591
4985
1.22
4.53
2.9
2.4
mosm/kgh2o
519.6
527.0
0.33
502
4183
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
98
623
1.59
4.53
5.0
4.7
%
1.7
1.7
0.11
92
584
(3019225) pH of Specimen
278
2146
1.32
4.49
2.7
2.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
431
3522
1.25
4.44
2.4
2.2
g/l
2.4
2.5
0.80
383
3255
(1616796) Gas panel - Central venous blood
69
406
1.71
4.32
2.9
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
144
1008
1.45
4.25
3.1
2.7
—
—
—
0
0
(3020891) Body temperature
96
622
1.56
4.12
3.3
4.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
653
5610
1.20
4.12
1.7
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
266
2067
1.31
4.12
7.1
5.4
mmol/l
104.6
104.8
0.32
257
2018
(3039000) Anion gap in Blood
58
330
1.77
4.09
5.1
7.0
mmol/l
11.3
11.0
0.30
53
295
(3018572) Chloride [Moles/volume] in Blood
58
331
1.76
4.06
5.1
7.0
mmol/l
105.6
105.1
0.40
53
296
(1761482) Bacteria [#/volume] in Urine by Culture
78
485
1.62
3.99
4.3
3.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
205
1543
1.35
3.97
4.8
3.4
kpa
5.8
5.8
0.21
198
1482
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2415
22909
1.14
3.95
2.8
2.6
u/l
36.2
30.6
2.49
2291
21850
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
387
1.69
3.93
2.5
2.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1661
15380
1.14
3.90
5.6
5.4
e9/l
0.0
0.0
0.13
1503
13562
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
154
2.09
3.72
1.3
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1650
15313
1.14
3.67
5.6
5.4
e9/l
0.5
0.5
0.15
1500
13545
(3002032) Base excess in Venous blood by calculation
200
1528
1.33
3.54
4.9
3.4
mmol/l
1.8
1.7
0.10
154
1213
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1185
10790
1.14
3.49
1.7
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1714
15982
1.13
3.47
5.7
5.6
e9/l
0.2
0.2
0.42
1581
14370
(3042631) Mycobacterium sp identified in Specimen
30
146
2.06
3.41
2.3
2.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
50
290
1.73
3.37
2.7
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3757
37126
1.42
3.31
16.2
14.0
e9/l
6.9
6.8
2.56
3682
36319
(3006504) Eosinophils/100 leukocytes in Blood
1541
14310
1.13
3.29
5.6
5.4
%
2.6
2.8
1.90
1443
13333
(3023520) Reticulocytes [#/volume] in Blood
171
1293
1.34
3.27
2.0
2.3
e9/l
67.5
73.1
1.32
133
943
(3044889) 12 lead EKG panel
1968
18552
1.12
3.24
2.7
2.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3756
37122
1.41
3.23
16.2
13.9
e12/l
4.4
4.5
10.54
3680
36348
(3019069) Monocytes/100 leukocytes in Blood
1547
14388
1.13
3.19
5.8
5.6
%
7.8
7.8
0.12
1461
13531
(3000963) Hemoglobin [Mass/volume] in Blood
3757
37138
1.41
3.18
16.2
14.0
g/l
132.7
133.0
0.83
3716
36769
(3035941) MCH [Entitic mass]
3755
37115
1.41
3.18
16.1
13.8
pg
30.2
30.0
20.09
3715
36753
(3005719) IgG [Mass/volume] in Serum or Plasma
269
2169
1.26
3.17
2.4
2.3
g/l
10.3
10.5
0.60
244
2004
(3048929) Epstein Barr virus Ab [Presence] in Serum
184
1413
1.32
3.17
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
3755
37117
1.41
3.16
16.1
13.9
fl
90.7
90.0
20.92
3714
36757
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3003
29076
1.15
3.14
9.1
7.3
ml/min/173m2
91.9
92.3
0.55
2439
23195
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
158
1.97
3.14
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
124
2.10
3.13
1.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3752
37090
1.39
3.07
16.2
13.9
e9/l
268.0
269.0
0.44
3686
36358
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
472
4047
1.19
3.05
2.6
1.9
mmol/l
2.4
2.4
0.73
410
3448
(3030467) Casts [#/volume] in Urine by Automated count
794
7097
1.15
3.02
2.7
2.6
e6/l
0.4
0.3
0.87
599
5175
(3022096) Basophils/100 leukocytes in Blood
1481
13778
1.12
2.99
5.7
5.5
%
0.6
0.7
1.69
1388
12826
(3024354) Oxygen [Partial pressure] in Venous blood
166
1269
1.32
2.97
4.4
2.8
kpa
4.3
4.6
1.23
159
1219
(3038515) Glucose [Moles/volume] in Venous blood
53
326
1.63
2.92
2.6
2.4
mmol/l
6.7
7.4
0.99
53
316
(3016879) Cocaine [Presence] in Urine
263
2138
1.25
2.91
2.6
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
226
1805
1.27
2.91
2.7
2.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
177
1.87
2.90
2.3
2.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
110
793
1.40
2.87
8.3
8.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
121
888
1.37
2.85
2.1
2.2
g/l
3.6
3.6
0.12
110
823
(3023183) Ammonium ion [Moles/volume] in Plasma
50
306
1.64
2.82
3.5
2.6
umol/l
31.8
32.7
0.13
44
268
(3028026) IgM [Mass/volume] in Serum or Plasma
208
1655
1.27
2.78
1.6
1.6
g/l
1.2
1.3
1.52
190
1541
(3022948) Iron [Moles/volume] in Serum or Plasma
460
3970
1.18
2.76
2.4
2.2
umol/l
14.8
14.6
0.22
412
3669
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
5
6
8.34
2.75
1.0
1.0
u/ml
0.9
6.6
—
5
6
(21494890) Protein electrophoresis panel - 24 hour Urine
22
104
2.12
2.74
2.1
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
369
3129
1.20
2.71
2.6
2.3
%
24.8
24.0
0.43
306
2693
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
73
493
1.49
2.71
2.0
1.8
ug/l
2.2
1.3
0.50
62
425
(3020779) Urea [Moles/volume] in Serum or Plasma
172
1342
1.29
2.69
8.9
6.7
mmol/l
8.9
7.5
1.66
161
1282
(3019309) Folate [Moles/volume] in Red Blood Cells
473
4105
1.17
2.66
1.7
1.7
nmol/l
1245.6
1188.5
0.73
366
3179
(21494755) Public health laboratory ask at order entry panel
434
5009
0.85
2.63
1.2
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
38
221
1.73
2.61
1.7
1.6
promille
1.3
1.3
0.00
26
174
(3000764) Benzodiazepines [Presence] in Urine
280
2322
1.22
2.60
2.5
2.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
345
2921
1.20
2.59
2.7
2.0
umol/l
5.9
5.3
0.33
280
2404
(3008037) Lactate [Moles/volume] in Venous blood
55
353
1.57
2.59
2.5
2.3
mmol/l
1.4
1.4
0.03
55
343
(3027008) Opiates [Presence] in Urine
281
2334
1.22
2.57
2.5
2.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
20
4.01
2.56
1.8
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
403
3464
1.18
2.55
1.3
1.3
iu/l
23.0
22.8
0.05
367
3021
(3025468) Yersinia sp identified in Specimen by Organism specific culture
51
324
1.58
2.51
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
84
593
1.43
2.51
1.4
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
104
762
1.37
2.51
4.5
2.5
%
0.6
0.7
0.41
95
722
(3028300) Cannabinoids [Presence] in Urine
281
2341
1.22
2.50
2.5
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
267
2214
1.22
2.49
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
51
325
1.58
2.48
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
358
3054
1.19
2.48
2.7
3.5
%
32.8
32.9
0.09
273
2258
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
494
4328
1.16
2.47
1.6
1.6
%
1.4
1.3
2.80
417
3906
(3019198) Lymphocytes [#/volume] in Blood
1690
15953
1.11
2.47
5.6
5.4
e9/l
2.0
2.0
0.09
1562
14406
(3005988) Vibrio sp identified in Specimen by Organism specific culture
51
326
1.57
2.46
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
52
334
1.56
2.45
1.5
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
51
2.55
2.44
3.6
4.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2907
28225
1.12
2.44
4.3
4.4
pmol/l
14.4
14.3
3.32
2683
26568
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
127
965
1.33
2.43
1.8
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
855
7784
1.13
2.43
2.9
2.7
e6/l
53.4
65.3
0.18
642
5734
(3023511) Choriogonadotropin [Units/volume] in Urine
265
2207
1.22
2.38
1.4
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
28
153
1.84
2.38
1.1
1.1
u/ml
3.0
4.2
0.16
16
85
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
146
1.86
2.37
3.0
2.4
%
60.3
55.4
0.40
17
93
(36304419) Bacteria [Presence] in Urine
786
7132
1.13
2.35
2.6
2.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
81
579
1.41
2.29
1.7
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
234
1938
1.22
2.24
2.2
2.3
%
1.6
1.7
0.62
204
1702
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
254
2122
1.21
2.23
1.6
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
115
874
1.33
2.23
1.8
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
52
343
1.52
2.21
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
51
335
1.53
2.21
1.5
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
9
5.56
2.21
1.0
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
16
73
2.20
2.20
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
41
256
1.61
2.20
3.8
1.2
u/ml
173.9
114.2
0.15
16
72
(3041806) Other cells [#/volume] in Blood by Manual count
15
310
0.48
2.19
1.2
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
23
122
1.89
2.15
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1591
15048
1.10
2.15
5.7
5.4
%
29.4
30.0
1.72
1490
14104
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
19
3.69
2.15
10.6
9.7
mmol/l
5.5
5.8
—
7
19
(21494814) CD8 cells/100 lymphocytes in Specimen
16
74
2.17
2.14
1.4
2.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
118
906
1.31
2.14
7.9
7.6
%
91.9
93.8
1.09
118
901
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
100
750
1.34
2.13
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
307
1.54
2.10
1.4
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
94
701
1.35
2.09
1.3
1.2
u/ml
321.2
261.6
1.12
70
480
(3018677) aPTT in Platelet poor plasma by Coagulation assay
363
3151
1.17
2.08
2.0
1.9
s
28.7
29.0
0.76
348
3019
(3018010) Neutrophils/100 leukocytes in Blood
1573
14889
1.10
2.07
5.4
5.2
%
56.7
56.5
0.36
1476
13994
(40761535) Cells panel - Urine sediment
242
2029
1.21
2.07
3.4
3.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
53
357
1.49
2.07
2.9
4.3
u/ml
0.4
0.4
0.21
29
199
(3047181) Lactate [Moles/volume] in Blood
82
600
1.37
2.05
4.6
5.0
mmol/l
1.2
1.2
0.15
75
526
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
624
5630
1.13
2.05
1.6
1.6
pmol/l
93834733.8
32979803.8
0.68
519
4897
(3019150) Specific gravity of Urine by Refractometry
782
7152
1.12
2.04
3.7
3.5
kg/l
1.0
1.0
0.94
110
1105
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
256
2161
1.20
2.04
1.6
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
177
1.70
2.02
1.4
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
63
2.23
2.00
2.4
3.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
57
393
1.46
1.99
1.4
1.5
—
—
—
0
0
(4268621)
26
439
0.59
1.98
2.1
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
202
1.64
1.95
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
39
249
1.57
1.95
3.6
5.2
mmol/l
6.3
6.7
0.26
32
200
(40768806) Pleura Pathology biopsy report
12
51
2.36
1.95
1.4
1.6
—
—
—
0
0
(1002224) Polysomnography panel
118
1499
0.78
1.92
1.1
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1091
10183
1.10
1.91
3.3
3.1
e6/l
72.6
77.0
0.10
721
6403
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3230
31669
1.12
1.91
4.9
5.0
mu/l
1.7
1.9
1.37
3002
30075
(3033658) Prothrombin time (PT) actual/Normal
691
6301
1.12
1.90
3.3
2.9
%
97.0
98.2
0.66
668
6073
(3016650) Hepatitis A virus Ab [Presence] in Serum
71
515
1.39
1.90
1.2
1.1
—
—
—
0
0
(44813793)
48
324
1.49
1.88
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
34
2.65
1.86
1.3
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2941
28705
1.10
1.86
12.7
11.0
%
13.4
13.4
0.69
2881
28119
(3047352) Trisomy 18 risk [Likelihood] in Fetus
242
2841
0.84
1.85
1.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
132
1051
1.26
1.85
3.3
2.7
ph
7.4
7.4
0.63
31
143
(3000991) Gas panel - Venous blood
164
1340
1.23
1.84
9.1
6.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
603
5469
1.12
1.83
2.5
2.3
e6/l
9.8
8.8
0.37
516
4680
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
23
3.05
1.80
1.6
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
133
1065
1.26
1.79
3.3
2.7
kpa
5.3
5.1
1.50
126
994
(3028679) Herpes simplex virus Ab [Presence] in Serum
43
287
1.50
1.79
1.2
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
47
2.34
1.77
1.4
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
285
2463
1.17
1.76
6.1
4.5
mmol/l
1.1
1.0
0.21
263
2290
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
43
629
0.68
1.76
1.2
1.2
u/ml
2.5
4.2
1.61
21
261
(3016038) Potassium [Moles/volume] in Urine
19
102
1.87
1.76
1.3
1.2
mmol/l
36.4
33.0
0.27
19
91
(3027944) Amphetamines [Presence] in Urine
269
2315
1.17
1.75
2.5
2.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
19
3.16
1.66
1.2
1.1
mmol/l
8.2
8.2
—
6
19
(3006184) Hemoglobin [Mass/volume] in Capillary blood
64
469
1.37
1.65
2.3
2.0
g/l
134.7
131.3
0.68
52
356
(3005033) Fetal Nuchal fold Thickness US
244
2829
0.85
1.64
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
126
1019
1.24
1.59
3.4
2.6
mmol/l
2.1
1.4
1.21
97
706
(3033799) Differential panel - Peritoneal fluid
6
20
3.00
1.58
1.8
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
52
371
1.41
1.58
2.3
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
28
175
1.60
1.57
1.2
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
127
1030
1.24
1.57
1.5
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
124
1003
1.24
1.57
1.3
1.3
u/l
18.6
19.6
0.14
93
818
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
25
152
1.65
1.56
6.0
7.2
mg/l
11.9
11.4
0.21
25
140
(3004588) Protein electrophoresis panel - Serum or Plasma
130
1058
1.24
1.56
1.9
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
253
2904
0.86
1.51
1.5
1.5
—
—
—
0
0
(4010399)
213
1826
1.18
1.49
1.3
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
819
7628
1.09
1.49
2.1
2.1
mg/l
2.7
2.6
0.42
702
6559
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
37
2.44
1.47
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
67
505
1.33
1.47
2.8
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
451
4078
1.12
1.47
2.4
2.3
e6/l
1.4
1.2
0.38
264
2182
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
134
1620
0.82
1.46
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
25
155
1.62
1.46
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
763
7093
1.09
1.45
1.9
1.9
u/l
170.1
145.7
0.35
720
6705
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
54
395
1.37
1.44
6.1
4.9
iu/ml
873.6
690.2
—
9
33
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
293
3314
0.87
1.43
1.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
261
1.46
1.43
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
1002
9431
1.08
1.43
1.7
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
245
1.47
1.42
1.1
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
137
1135
1.21
1.41
1.8
1.6
iu/ml
0.0
0.2
1.21
28
200
(3007916) DNA double strand Ab [Titer] in Serum
9
40
2.25
1.40
1.0
1.5
—
72.4
—
0
5
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
173
1.56
1.39
1.0
1.1
%
101.2
93.4
0.76
12
63
(40768441) Liver Pathology biopsy report
27
173
1.56
1.39
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1069
10102
1.08
1.37
3.2
2.6
u/l
28.0
27.7
0.14
1014
9646
(3021879) Hepatitis B virus core Ab [Presence] in Serum
394
3551
1.12
1.37
1.5
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
98
786
1.25
1.37
1.8
2.0
g/l
1.4
1.3
0.43
83
679
(3010144) Erythrocytes [#/volume] in Synovial fluid
28
182
1.54
1.37
1.3
1.5
e6/l
69104.9
99128.8
0.14
14
123
(3011412) CD3 cells [#/volume] in Blood
35
239
1.47
1.36
1.7
2.5
e9/l
1.5
1.4
0.16
21
138
(3044007) Cell count panel - Peritoneal fluid
6
23
2.61
1.36
2.0
2.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
23
2.61
1.36
1.0
1.4
%
50.8
45.1
—
6
18
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
29
191
1.52
1.34
1.4
2.1
%
10.9
12.3
0.31
11
117
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
167
1.56
1.34
1.0
1.1
%
99.6
94.4
0.32
11
63
(3000093) Morphology [Interpretation] in Blood Narrative
26
167
1.56
1.34
1.2
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
375
1.36
1.34
3.0
1.5
mg/l
54.0
31.9
0.72
36
312
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
42
2.15
1.33
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
733
6831
1.09
1.32
1.2
1.3
iu/ml
66.0
28.2
0.46
249
2103
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
41
291
1.41
1.32
1.1
1.1
ratio
1.0
1.0
0.03
12
107
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
376
1.36
1.32
3.0
1.5
mg/l
30.8
38.9
0.23
36
313
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
43
2.10
1.30
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
78
614
1.28
1.29
2.7
2.7
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
18
2.78
1.28
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
670
7195
0.92
1.27
1.6
1.6
mmol/l
1.4
1.3
0.51
550
6301
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
84
1.79
1.27
1.3
1.7
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
35
2.29
1.26
1.1
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
35
2.29
1.26
1.1
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
414
1.33
1.26
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
211
1.47
1.25
1.2
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
700
6528
1.09
1.25
1.3
1.3
u/ml
11.2
9.0
0.42
293
2778
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
511
1.30
1.24
1.2
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
70
1.86
1.23
1.2
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
156
1328
1.18
1.23
2.3
1.5
g/l
66.7
67.6
0.97
142
1216
(3048689) Calprotectin [Mass/mass] in Stool
567
5243
1.10
1.22
2.5
2.4
ug/g
109.1
91.8
0.56
436
4083
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
19
2.63
1.21
1.2
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
38
272
1.40
1.19
3.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
169
1958
0.86
1.19
2.2
2.0
ml/min/173m2
73.0
78.9
1.24
67
724
(3000330) Specific gravity of Urine by Test strip
152
1298
1.18
1.17
4.2
2.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
127
0.47
1.16
1.5
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
134
1134
1.19
1.15
3.4
2.4
e6/l
0.3
0.2
0.14
129
1073
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
775
7283
1.08
1.15
1.7
1.7
mg/l
1.1
0.8
0.67
577
5324
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
224
2535
0.88
1.15
2.3
2.1
u/l
37.2
34.7
0.15
193
2141
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
421
1.31
1.14
1.3
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
126
1.59
1.14
1.5
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3034
29852
1.08
1.11
3.4
3.5
mmol/l
5.6
5.6
0.80
2805
27998
(3015171) Extractable nuclear Ab [Units/volume] in Serum
191
1669
1.15
1.11
1.2
1.3
u/ml
0.3
1.2
2.10
19
129
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
143
1.54
1.11
1.2
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
143
1.54
1.11
1.2
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
143
1.54
1.11
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
71
565
1.26
1.11
1.4
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
73
1.78
1.10
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
413
3783
1.10
1.10
2.6
2.4
e6/l
5.7
5.2
0.33
226
1889
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
306
2760
1.12
1.09
3.4
3.1
pmol/l
4.6
4.5
0.55
269
2465
(3047007) Chlamydophila sp Ab [Presence] in Serum
76
611
1.25
1.09
1.3
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
66
1.82
1.09
1.2
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
50
649
0.77
1.08
1.2
1.2
u/ml
3.3
3.0
0.07
23
216
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1388
13338
1.06
1.08
2.3
2.2
nmol/l
75.3
74.7
0.40
1276
12418
(3000012) Reticulocyte production index
15
89
1.69
1.07
1.1
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
13
74
1.76
1.06
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
245
1.39
1.05
1.5
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
67
1.79
1.04
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
67
1.79
1.04
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
67
1.79
1.04
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
67
1.79
1.04
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
67
1.79
1.04
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
375
1.31
1.04
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
95
788
1.21
1.03
1.9
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
212
1.42
1.03
1.2
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
42
315
1.34
1.02
1.2
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
17
106
1.61
1.02
1.3
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
20
130
1.54
1.02
1.4
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
300
2716
1.11
1.02
1.8
1.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
147
1.50
1.00
2.7
2.7
umol/l
156.5
165.8
0.07
16
83
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
72
583
1.24
0.99
2.1
2.2
ug/l
1090.6
429.0
0.44
63
517
(3017569) Oxygen content in Arterial blood
11
61
1.81
0.98
4.6
2.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(4024509)
20
295
0.68
0.96
1.3
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
319
1.32
0.96
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
67
541
1.24
0.96
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
470
4365
1.09
0.95
2.9
2.6
ng/l
1035.9
802.8
0.68
390
3505
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
233
1.38
0.95
1.3
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
40
523
0.76
0.94
1.7
1.5
g/l
0.5
0.6
0.48
27
392
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
109
1.56
0.93
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
64
517
1.24
0.92
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
39
296
1.32
0.90
1.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
403
4349
0.92
0.90
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
561
5264
1.08
0.89
1.4
1.4
titre
600.3
622.1
0.08
116
1084
(46235168) Fasting glucose [Moles/volume] in Blood
6
29
2.07
0.89
1.0
1.0
—
6.2
—
0
11
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
29
2.07
0.89
10.5
6.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
158
1390
1.14
0.88
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
554
5898
0.93
0.88
1.9
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
333
3062
1.10
0.86
1.8
1.9
nmol/l
395.6
377.7
0.87
311
2800
(3018133) Calcium [Moles/volume] in Urine
8
44
1.82
0.85
1.1
1.6
mmol/l
2.3
2.9
—
8
39
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
39
300
1.30
0.84
1.2
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
127
1106
1.15
0.83
1.3
1.5
nmol/l
0.5
0.5
0.09
98
946
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
37
283
1.31
0.83
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
205
1.37
0.83
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
140
0.57
0.82
3.4
4.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
32
1.88
0.81
3.3
5.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
81
1.61
0.81
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
302
1.29
0.81
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
87
737
1.18
0.81
3.5
2.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
129
1128
1.15
0.81
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
50
620
0.80
0.80
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
353
3269
1.09
0.79
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
31
408
0.76
0.79
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
164
1.40
0.79
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2846
28863
0.95
0.79
3.9
3.9
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
47
586
0.80
0.79
1.1
1.1
%
113.8
117.3
0.23
40
529
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
33
430
0.77
0.79
2.2
2.7
ug/min
221.4
85.0
0.29
22
286
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
35
268
1.31
0.79
1.6
1.8
mg/l
18.2
27.6
—
10
72
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
0.7
—
0
20
(40762814) Titanium [Mass/volume] in Blood
0
25
0.00
0.79
0.0
2.1
—
3.8
—
0
9
(3014111) Lactate [Moles/volume] in Serum or Plasma
169
1508
1.13
0.78
7.3
5.2
mmol/l
1.4
1.3
0.58
164
1446
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
37
286
1.30
0.78
1.7
1.7
%
53.6
52.8
0.05
25
175
(3003157) Bacteria [#/volume] in Mother's milk
0
27
0.00
0.77
0.0
7.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
73
612
1.20
0.77
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
126
0.55
0.77
1.3
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
95
816
1.17
0.76
1.3
1.3
titre
188.0
95.9
—
10
75
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
221
0.68
0.75
1.3
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
13
197
0.66
0.75
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
132
0.61
0.73
1.4
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
39
1.80
0.72
1.7
2.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
95
821
1.16
0.72
1.6
1.7
titre
225.0
379.5
—
5
43
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
18
253
0.71
0.71
12.7
12.8
nmol/l
996.4
854.0
0.73
18
245
(3017732) Neutrophils [#/volume] in Blood
258
2371
1.09
0.71
2.3
2.0
e9/l
4.2
4.2
0.12
204
1976
(3022145) Colonoscopy Study observation
324
3008
1.08
0.71
1.4
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
59
490
1.21
0.70
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
170
1532
1.11
0.69
1.2
1.2
u/l
9.0
10.0
0.51
146
1280
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
118
1.44
0.69
1.7
2.7
%
55.2
48.0
—
6
47
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
328
1.25
0.69
1.3
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
27
1.85
0.68
1.0
1.1
umol/24h
1.6
1.4
—
5
27
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
161
1.37
0.68
2.1
2.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
94
1.49
0.66
1.1
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
95
0.53
0.66
2.6
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
19
260
0.73
0.66
16.4
18.5
nmol/l
1656.4
1507.5
0.46
19
252
(3045716) Anion gap in Serum or Plasma
13
86
1.51
0.66
10.2
2.1
mmol/l
10.3
9.2
—
7
65
(3045788) Cell count panel - Pleural fluid
11
70
1.57
0.65
1.4
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
10
62
1.61
0.65
1.1
1.1
—
288.0
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
132
1179
1.12
0.64
1.3
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
18
247
0.73
0.64
1.2
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
584
5560
1.06
0.64
1.4
1.4
nmol/l
21.2
21.3
0.10
503
4918
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1072
10373
1.05
0.62
1.7
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
165
1.34
0.60
2.0
2.9
e6/l
771.0
886.3
0.34
11
77
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.1
—
19.7
—
0
21
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
135
1498
0.90
0.59
1.6
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
678
6497
1.05
0.59
2.4
1.9
umol/l
4987.8
3282.6
0.49
595
5747
(3042733) HLA Ab [Presence] in Serum
10
64
1.56
0.58
2.5
4.6
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
0
23
0.00
0.58
0.0
1.2
—
0.2
—
0
8
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
54
1.48
0.57
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
289
2703
1.07
0.56
1.2
1.3
u/ml
240.5
170.3
0.52
262
2504
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
55
1.46
0.56
2.5
2.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
194
1.29
0.55
3.4
3.4
nmol/l
0.8
0.8
0.19
19
152
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
25
194
1.29
0.55
1.0
1.1
u/ml
15.5
6.1
—
5
38
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
203
1.28
0.55
1.6
1.6
%
36.0
40.3
0.25
16
115
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
1.1
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
1.1
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
148
0.67
0.55
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2706
26733
1.04
0.54
4.0
4.2
mmol/mol
36.8
37.4
4.20
2515
25291
(3035880) pH of Pleural fluid
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
60
1.50
0.54
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
84
951
0.88
0.53
1.7
1.6
mmol/l
7.8
7.6
0.39
56
574
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
562
1.16
0.53
2.4
1.3
g/l
10.0
10.4
0.30
53
487
(3024471) HLA-A [Type]
9
62
1.45
0.53
1.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
23
178
1.29
0.53
2.5
2.9
mg/l
12.8
64.6
0.83
13
118
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
66
1.52
0.52
1.1
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
552
5764
0.95
0.52
3.2
3.3
mg/l
617.6
363.3
0.49
357
3500
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
96
0.62
0.52
1.0
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
94
837
1.13
0.51
7.4
3.8
mmol/l
23.9
24.1
0.26
79
725
(44816559) Phosphatidylethanol [Mass/volume] in Blood
80
705
1.14
0.51
1.3
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
18
135
1.33
0.51
2.2
2.0
ug/l
1.5
1.1
0.27
18
125
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
41
1.46
0.50
1.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
613
1.14
0.49
2.3
1.3
g/l
3.4
3.7
1.71
48
445
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
613
1.14
0.49
2.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
67
1.49
0.49
1.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
67
1.49
0.49
1.0
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
780
7539
1.04
0.49
3.4
3.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
741
7155
1.04
0.49
3.4
3.2
mmol/l
7.3
7.4
0.20
632
6195
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
169
1558
1.09
0.49
1.1
1.2
ug/l
4.8
3.1
0.45
160
1480
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
614
1.14
0.49
2.3
1.3
g/l
7.3
7.3
0.06
51
472
(1761868) Lipid panel - Serum or Plasma
1319
12883
1.04
0.49
2.2
2.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
107
1185
0.90
0.48
2.4
2.1
iu/l
103.0
4.1
0.50
55
481
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
25
312
0.80
0.48
1.1
1.1
—
58.0
—
0
6
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
33
271
1.22
0.48
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
223
0.76
0.48
1.4
1.4
umol/l
11.9
9.9
0.46
17
209
(3015183) Erythrocyte sedimentation rate
32
262
1.22
0.48
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
145
1329
1.09
0.48
1.9
2.0
ug/l
10.4
5.1
0.50
133
1150
(3008898) HLA-B27 [Presence]
206
1918
1.08
0.47
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
10
68
1.47
0.47
1.4
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.46
1.1
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.46
1.1
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
85
1.41
0.46
1.1
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
24
299
0.80
0.46
1.5
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
209
1.25
0.46
1.2
1.2
u/l
56.4
62.0
0.23
19
143
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
100
902
1.11
0.46
1.3
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
118
0.68
0.45
1.1
1.3
—
877.5
—
0
8
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
14
103
1.36
0.45
1.1
1.2
—
—
—
0
0
(4027681)
35
292
1.20
0.45
1.3
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
50
1.40
0.45
1.3
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
156
1.28
0.45
2.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
86
1.40
0.44
1.1
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
68
768
0.88
0.44
1.9
2.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
55
479
1.15
0.44
1.9
1.3
g/l
0.0
0.0
0.68
50
447
(3045414) Leukocytes [Presence] in Urine
162
1502
1.08
0.43
1.5
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
584
1.13
0.42
2.3
1.3
g/l
3.0
3.0
0.06
51
461
(4306422)
54
617
0.87
0.42
1.3
1.2
—
—
—
0
0
(4133840)
6
92
0.65
0.42
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
95
0.63
0.42
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
30
249
1.21
0.41
1.1
1.1
miu/ml
1681.9
1467.3
0.36
30
249
(4015189)
5
33
1.52
0.41
1.8
3.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
1.4
1.1
—
—
—
0
0
(3003843) Paprika IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.0
—
0
11
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
16
0.00
0.41
0.0
8.2
—
77.5
—
0
11
(44790047)
28
231
1.21
0.41
1.3
1.4
—
—
—
0
0
(44790048)
28
231
1.21
0.41
1.3
1.4
—
—
—
0
0
(44806118)
28
231
1.21
0.41
1.3
1.4
—
—
—
0
0
(44790049)
28
231
1.21
0.41
1.3
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
90
814
1.11
0.41
1.3
1.2
titre
938.0
1149.3
—
5
46
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3017166) Chili Pepper IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.1
—
0
11
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
79
1.39
0.40
2.5
3.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
142
1314
1.08
0.40
2.3
2.7
ng/l
163.4
126.2
0.58
124
1160
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
132
1.29
0.40
1.5
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
59
521
1.13
0.40
2.8
1.4
g/l
0.4
0.3
0.20
50
466
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
970
9459
1.03
0.40
1.3
1.3
u/ml
1.6
1.6
0.01
315
2824
(3006653) Thiamine [Moles/volume] in Blood
11
149
0.74
0.40
1.2
1.6
nmol/l
123.9
125.6
0.04
11
149
(3024932) HLA-DR beta [Type]
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
19
0.00
0.39
0.0
1.4
—
4.8
—
0
8
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
23.2
—
0
19
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
112
1029
1.09
0.38
1.2
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
712
6914
1.04
0.37
6.0
4.8
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
115
0.70
0.37
2.5
2.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
258
2449
1.06
0.37
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1079
10558
1.03
0.36
1.7
1.8
pmol/l
97.0
99.6
0.93
573
5587
(3035933) Granulocytes/100 leukocytes in Blood
10
135
0.74
0.36
1.8
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
76
0.66
0.35
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
78
0.64
0.35
1.2
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
117
1264
0.92
0.35
1.1
1.1
u/ml
2.0
5.0
1.73
17
204
(3032057) Clostridioides difficile [Presence] in Stool
6
42
1.43
0.35
1.8
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
86
784
1.10
0.35
2.0
2.1
%
12.8
13.1
2.18
86
774
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
10
134
0.75
0.34
1.0
1.1
nmol/l
6.8
5.6
—
10
126
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
341
0.85
0.34
1.3
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
36
311
1.16
0.34
2.6
3.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
265
0.83
0.34
1.1
1.1
u/l
1.0
1.0
—
10
107
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
45
1.33
0.33
1.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
6
86
0.70
0.33
1.0
1.1
—
4.1
—
0
17
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
101
1.29
0.31
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
101
1.29
0.31
1.4
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
97
0.72
0.30
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
85
923
0.92
0.30
1.2
1.3
u/ml
77.1
44.8
—
10
84
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
347
0.86
0.30
1.5
1.4
g/l
7.5
6.3
0.48
21
239
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
138
1.23
0.30
1.2
1.2
pmol/l
23.4
15.7
1.35
17
125
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
54
1.30
0.30
1.1
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
40
353
1.13
0.30
1.3
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
346
0.87
0.29
1.5
1.4
g/l
0.4
0.4
0.16
21
236
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
346
0.87
0.29
1.5
1.4
g/l
2.6
2.9
0.77
21
234
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
8
107
0.75
0.29
2.1
2.4
nmol/l
166.1
164.3
—
8
92
(43055514) Macroprolactin [Presence] in Serum or Plasma
17
206
0.82
0.29
1.5
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
108
0.74
0.29
2.6
1.8
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
121
1.24
0.28
2.0
1.6
u/l
16.7
5.6
—
9
65
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
103
1.26
0.28
1.4
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
85
1.29
0.28
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
85
1.29
0.28
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
85
1.29
0.28
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
63
689
0.91
0.27
1.1
1.1
u/ml
1.2
3.0
3.40
37
380
(3017704) Immunofixation for Urine
8
64
1.25
0.27
1.6
1.1
—
—
—
0
0
(44806071)
8
64
1.25
0.27
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
65
1.23
0.27
1.3
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
55
604
0.91
0.26
3.0
3.4
mg/l
35.9
23.1
0.73
24
374
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
95
1.26
0.26
2.0
1.5
ug/l
7.6
8.2
0.39
12
95
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
361
3729
0.96
0.26
1.4
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
169
1.18
0.25
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
75
694
1.08
0.25
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
267
2773
0.96
0.25
1.6
1.6
mu/l
311.2
305.7
0.06
237
2452
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
130
1228
1.06
0.25
2.1
2.1
u/l
39.0
38.9
0.01
125
1140
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
188
1.17
0.25
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
21
179
1.17
0.25
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
87
811
1.07
0.25
1.2
1.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
13
105
1.24
0.24
1.0
1.1
%
—
2.1
—
0
11
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
98
918
1.07
0.24
1.4
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
76
1.18
0.24
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
76
1.18
0.24
1.4
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
173
1813
0.95
0.24
1.5
1.7
mg/l
3.3
3.7
0.31
112
1215
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
80
744
1.08
0.24
1.2
1.3
e6/l
83.2
6612.6
0.74
66
618
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
80
744
1.08
0.24
1.2
1.3
e6/l
159.0
15.8
0.47
64
586
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
90
962
0.93
0.24
1.1
1.1
—
—
—
0
0
(4211845)
22
189
1.16
0.24
2.7
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
794
7789
1.02
0.24
1.4
1.3
g/l
2.2
2.1
0.36
509
4949
(3014148) Varicella zoster virus Ab [Titer] in Serum
80
745
1.08
0.24
1.3
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
14
115
1.22
0.23
1.5
1.9
ml
1735.7
2001.9
0.54
14
106
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
134
1.19
0.22
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
88
1.25
0.22
2.0
2.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
92
0.76
0.22
1.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
167
1597
1.05
0.22
3.3
3.3
ng/l
82.0
77.2
0.25
151
1394
(3020491) Glucose [Moles/volume] in Blood
31
276
1.12
0.22
1.5
1.6
mmol/l
5.5
5.7
0.13
24
217
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
15
178
0.84
0.22
1.1
1.2
g/l
0.3
0.3
—
10
140
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
144
1.18
0.22
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
210
1.14
0.21
1.1
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
28
248
1.13
0.21
1.9
1.8
u/ml
5.1
25.2
0.51
22
189
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
102
0.78
0.21
1.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
43
1.16
0.21
1.8
1.1
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
25.7
—
0
13
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
102.4
—
0
13
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
20
173
1.16
0.20
2.8
2.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
55
508
1.08
0.20
1.5
1.7
e6/l
6715.0
8446.2
0.33
43
372
(3009542) Hematocrit [Volume Fraction] of Blood
3175
31877
0.98
0.20
11.1
10.1
%
39.3
39.5
0.92
2488
26051
(3022217) INR in Platelet poor plasma by Coagulation assay
220
2122
1.04
0.20
8.0
14.6
inr
1.2
1.1
0.25
47
371
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
249
1.13
0.20
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
136
1.18
0.20
1.8
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
193
1.14
0.19
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2982
29687
1.02
0.19
3.0
3.1
mmol/l
1.2
1.2
1.45
2792
28111
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
165
0.85
0.19
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
481
1.08
0.19
2.0
1.3
g/l
38.0
38.8
0.42
44
422
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
114
1085
1.05
0.19
1.1
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
85
803
1.06
0.18
3.1
2.5
g/l
0.4
0.4
0.01
29
266
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
261
1.11
0.18
1.4
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
24
269
0.89
0.18
1.6
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
310
0.90
0.17
1.2
1.2
u/ml
0.1
0.9
—
9
103
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1882
18961
0.99
0.17
2.9
3.0
ug/l
73.9
60.2
3.16
1754
17984
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
16
184
0.87
0.17
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
110
1.18
0.17
1.1
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
63
1.11
0.17
1.1
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
23
205
1.12
0.17
1.0
1.1
%
82.8
89.4
0.46
16
166
(3024928) Oxygen saturation in Venous blood
33
361
0.91
0.17
9.4
3.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
62
582
1.07
0.17
1.1
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
42
388
1.08
0.16
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
236
2429
0.97
0.16
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
106
1109
0.95
0.16
1.1
1.1
u/ml
1.0
1.3
0.15
39
413
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
36
331
1.09
0.16
1.6
1.4
pmol/l
353.4
362.6
0.06
28
255
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
36
331
1.09
0.16
1.4
2.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
342
3498
0.98
0.16
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
413
4047
1.02
0.16
2.7
2.8
ng/l
105.4
312.2
2.04
196
2111
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
11
130
0.85
0.16
2.5
2.5
umol/l
44.2
49.5
0.25
11
113
(3039162) Centromere protein B Ab [Units/volume] in Serum
47
504
0.93
0.16
1.2
1.3
—
57.4
—
0
30
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
320
3126
1.03
0.15
1.5
1.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
13
111
1.17
0.15
1.0
1.1
%
102.8
106.1
0.19
13
105
(3042517) Benzodiazepines panel - Urine
8
73
1.10
0.15
2.6
2.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
38
351
1.08
0.15
1.0
1.1
u/ml
0.4
2.0
—
9
103
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
78
1.15
0.15
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
324
3314
0.98
0.15
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
73
692
1.06
0.15
1.2
1.3
ug/g
349.8
325.1
0.37
41
330
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
243
2366
1.03
0.15
1.3
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
307
0.91
0.15
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
307
0.91
0.15
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
307
0.91
0.15
1.3
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
161
0.87
0.15
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
80
1.13
0.15
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
81
1.11
0.15
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
207
1.11
0.15
2.1
2.7
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
41
381
1.08
0.14
1.2
1.1
nmol/l
—
0.4
—
0
13
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
415
4072
1.02
0.14
1.5
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
7
86
0.81
0.14
1.3
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
39
362
1.08
0.14
1.1
1.1
mg/l
193.7
204.1
0.25
31
317
(3017446) Testosterone [Moles/volume] in Serum or Plasma
64
675
0.95
0.14
1.2
1.3
nmol/l
1.3
1.4
0.38
51
564
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
393
3857
1.02
0.14
1.2
1.2
iu/ml
166.1
155.6
0.19
150
1550
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
234
2282
1.03
0.13
1.4
1.3
miu/ml
228.1
240.6
0.24
126
1195
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
78
744
1.05
0.13
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
305
0.92
0.13
1.3
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
29
315
0.92
0.13
1.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
15
132
1.14
0.13
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
304
0.92
0.13
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
304
0.92
0.13
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
209
2143
0.97
0.12
2.9
2.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
343
3495
0.98
0.12
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
341
3472
0.98
0.12
1.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
385
1.07
0.12
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
95
1.16
0.11
1.0
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
11
95
1.16
0.11
1.3
2.3
e6/l
221.7
148.4
—
6
56
(3038177) Helicobacter pylori Ab [Presence] in Serum
68
711
0.96
0.11
1.2
1.2
—
—
—
0
0
(4062490)
32
343
0.93
0.11
1.5
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
86
1.16
0.11
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
72
750
0.96
0.11
2.6
2.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
21
192
1.09
0.10
2.4
2.8
—
22.6
—
0
5
(4094501)
51
536
0.95
0.10
1.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
19
173
1.10
0.10
1.2
1.2
—
—
—
0
0
(4146454)
16
177
0.90
0.10
2.3
2.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
212
1.09
0.10
2.9
2.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
343
3483
0.98
0.10
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
598
5915
1.01
0.10
1.4
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
238
2425
0.98
0.10
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
45
1.11
0.09
1.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
45
428
1.05
0.09
1.4
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
40
379
1.06
0.09
1.1
1.1
mg/l
36.5
35.3
0.07
28
313
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
157
1534
1.02
0.09
1.4
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
71
684
1.04
0.09
1.1
1.1
au/ml
9.4
11.8
—
8
45
(3010726) Horse dander IgE Ab [Units/volume] in Serum
96
931
1.03
0.09
1.1
1.1
u/ml
1.7
1.4
0.13
16
241
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
280
2845
0.98
0.09
1.6
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3085
30915
0.99
0.09
3.2
3.4
mmol/l
1.6
1.6
0.07
2904
29367
(4198724)
25
233
1.07
0.09
1.5
3.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
117
1200
0.97
0.08
2.4
2.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
19
175
1.09
0.08
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
58
1.03
0.08
1.3
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
119
1161
1.03
0.08
2.1
1.9
g/l
1.1
1.2
0.52
110
1096
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
36
379
0.95
0.08
1.3
1.3
—
36.1
—
0
8
(3000492) Spirometry study
320
3158
1.01
0.08
1.3
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
176
1.08
0.07
2.1
2.2
—
—
—
0
0
(4034850)
101
985
1.03
0.07
7.3
7.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
126
1233
1.02
0.07
2.9
2.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
81
833
0.97
0.07
1.0
1.1
u/ml
6.2
4.5
0.18
26
320
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
7
84
0.83
0.07
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
84
1.07
0.07
5.3
2.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
85
1.06
0.07
1.7
2.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
118
1.10
0.07
3.4
3.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
89
1.12
0.06
2.0
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
69
670
1.03
0.06
1.0
1.1
u/ml
0.0
0.4
—
8
138
(3003740) Influenza virus B Ag [Presence] in Specimen
83
809
1.03
0.06
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
103
0.87
0.06
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
203
0.94
0.06
1.7
2.1
u/field
2.6
2.3
—
8
98
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
287
2902
0.99
0.06
1.3
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
34
355
0.96
0.06
1.3
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
83
811
1.02
0.05
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
32
334
0.96
0.05
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
77
752
1.02
0.05
1.3
1.2
—
7.9
—
0
7
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
161
0.93
0.05
1.2
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
110
0.91
0.05
2.7
2.2
umol/l
14.4
15.4
—
10
110
(3004616) Nuclear Ab [Presence] in Serum
41
424
0.97
0.05
1.5
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
21
199
1.06
0.04
1.5
1.5
nmol/l
1.6
1.5
0.38
21
178
(3023430) Cat dander IgE Ab [Units/volume] in Serum
79
774
1.02
0.04
1.1
1.1
u/ml
3.8
4.4
0.17
25
316
(40768797) Stomach Pathology biopsy report
392
3892
1.01
0.04
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
77
786
0.98
0.04
1.5
1.5
mmol/l
7.7
6.8
0.92
61
550
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
115
1132
1.02
0.04
1.2
1.3
u/ml
57.0
39.6
—
8
79
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
645
6483
0.99
0.04
1.4
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
138
1362
1.01
0.04
1.5
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
168
1663
1.01
0.03
1.9
2.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
237
2351
1.01
0.03
1.2
1.3
au/ml
34.7
33.7
—
5
93
(3003327) Ova and parasites identified in Stool by Light microscopy
149
1474
1.01
0.03
1.7
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
43
419
1.03
0.03
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
43
419
1.03
0.03
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
598
6004
1.00
0.03
3.9
4.0
mg/mmol
9.5
11.3
0.42
374
3747
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
40
390
1.03
0.02
1.6
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
26
251
1.04
0.02
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
152
1.05
0.02
1.3
1.6
u/field
1.1
3.2
—
8
107
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
31
301
1.03
0.02
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
37
361
1.03
0.02
1.1
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
96
949
1.01
0.02
2.1
1.9
%
92.7
94.5
0.30
86
854
(3014765) Yersinia sp identified in Stool by Organism specific culture
101
1021
0.99
0.02
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
100
1009
0.99
0.01
1.2
1.3
u/ml
11.5
6.3
0.31
12
97
(42529406) Shigella sp [Presence] in Stool by Culture
102
1029
0.99
0.01
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
115
1141
1.01
0.01
1.6
1.8
s
20.8
20.5
0.35
89
921
(3034274) Bile acid [Moles/volume] in Serum --fasting
137
1379
0.99
0.01
2.1
2.2
umol/l
4.4
4.9
0.42
98
1017
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
38
373
1.02
0.01
1.2
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
114
1132
1.01
0.01
2.2
1.9
g/l
0.2
0.2
0.19
106
1067
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
253
2539
1.00
0.01
2.2
2.3
au/ml
21.1
21.7
0.03
18
191
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
56
567
0.99
0.01
1.4
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
97
977
0.99
0.01
1.1
1.1
u/ml
7.9
5.2
0.48
40
520
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
103
1023
1.01
0.00
1.3
1.3
u/ml
12.3
8.9
0.17
15
174
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3108
31071
1.00
0.00
3.3
3.4
mmol/l
4.8
4.8
0.25
2933
29568
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
24
234
1.03
0.00
1.1
1.0
mg/l
319.3
298.6
0.80
24
213
(3044941) Cell count panel - Synovial fluid
35
356
0.98
0.00
1.2
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
48
474
1.01
0.00
4.3
2.5
nmol/l
0.9
0.8
0.38
41
398
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
98
1.02
0.00
1.0
1.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
10
98
1.02
0.00
1.1
1.0
u/ml
0.1
1.7
—
5
69
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
32
322
0.99
0.00
1.4
1.6
mmol/l
5.5
5.1
1.43
32
308
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
17
165
1.03
0.00
1.2
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
28
275
1.02
0.00
1.0
1.1
iu/ml
8.2
8.8
—
6
67
(3008401) Mugwort IgE Ab [Units/volume] in Serum
92
922
1.00
0.00
1.0
1.1
u/ml
2.5
0.9
0.52
29
379
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3135
31355
1.00
0.00
3.5
3.7
mmol/l
2.9
2.9
0.96
2934
29645
(3029075) Extractable nuclear Ab panel - Serum
10
101
0.99
0.00
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
111
0.99
0.00
1.1
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
261
1.00
0.00
1.1
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
36
359
1.00
0.00
1.0
1.0
u/ml
1.9
0.8
—
7
81
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
44
439
1.00
0.00
2.1
1.3
g/l
0.0
0.0
0.00
39
413
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
34
336
1.01
0.00
1.6
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
11
106
1.04
0.00
1.0
1.1
iu/ml
—
4.3
—
0
10
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
164
0.98
0.00
1.3
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
44
444
0.99
0.00
2.1
1.3
g/l
0.0
0.0
0.00
39
415
(3035637) Corticotropin [Mass/volume] in Plasma
32
317
1.01
0.00
1.2
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
56
563
0.99
0.00
1.1
1.2
iu/ml
58.4
18479.0
0.64
21
145
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
102
1017
1.00
0.00
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
133
0.98
0.00
2.6
2.4
%
11.3
10.7
0.25
13
133
(3037756) Immunofixation for Serum or Plasma
24
237
1.01
0.00
1.6
1.2
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
220.0
—
0
6
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.4
—
0.2
—
0
8
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
64
0.94
0.00
1.0
1.3
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
52
0.96
0.00
1.0
1.3
pmol/l
280.2
330.7
—
5
33
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
1.2
ng/l
102.4
85.0
—
5
52
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
65
0.92
0.00
5.2
6.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
56
0.89
0.00
1.4
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
59
0.85
0.00
1.0
1.2
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
308.8
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
79
1.01
0.00
1.1
1.1
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.6
—
2.6
—
0
8
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.8
—
0
6
(3049242) von Willebrand panel - Platelet poor plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
1281.4
—
0
7
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.1
—
210.2
—
0
9
(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
22
220
1.00
0.00
2.3
2.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_CERVIX_UTERI_EXALLC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_INSITU_CERVIX_UTERI_EXALLC | 1.416 [1.21, 1.65] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.175 |
During the follow-up period (1.1.1998 — 31.12.2019), 235 out of 3908 females with CD2_INSITU_CERVIX_UTERI_EXALLC died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_CERVIX_UTERI_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.151% | No data |
| 5 | 0.802% | No data |
| 10 | 1.94% | No data |
| 15 | 3.761% | No data |
| 20 | 6.487% | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_CERVIX_UTERI_EXALLC – Carcinoma in situ of cervix uteri
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data